Digoxin

地高辛

Report date: 2026/04/16 20:00:17
NME

Base Information

Drug NameDigoxin
Drug Alias Name异羟基洋地黄毒苷DigoxinaDigoxine狄戈辛Digoxinum +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/potassium-transporting ATPase inhibitors
TargetsSodium/potassium-transporting ATPase
Therapy Area/IndicationsAlcohol-Induced DisordersDrug-Related Side Effects and Adverse ReactionsInflammation +[27] 
Global Approved IndicationsHypothyroidismHyperthyroidismHeart Failure +[8] 
Approved Indications in ChinaHeart FailureAtrial FibrillationArrhythmias, Cardiac
Original Approved Country/TerritoryUnited States
Original Approved Date1954/11/16
Country/TerritoryUnited StatesTunisiaUnited Kingdom +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesTaiyo Pharma Co ltdYale UniversityUniversity Of Monastir +[9] 
Inactive CompaniesTheracos IncSidney Kimmel Cancer Center At Thomas Jefferson UniversityNational Heart, Lung, And Blood Institute (Nhlbi) +[5] 
Active IndicationsInflammationHypothyroidismHyperthyroidism +[18] 
Inactive IndicationsAlcohol-Induced DisordersDrug-Related Side Effects and Adverse ReactionsArrhythmia, Sinus +[9] 

Other Information

ATC CodeC01AA05
Related LinksWikipediaDrugBankKEGG